Valeant’s Shares Fall on Report’s Fraud Claim by Unknown Author

By Unknown Author

A research firm’s report that all but called Valeant the pharmaceutical equivalent of Enron hit the stock market like a bomb Wednesday morning.

Published: October 22, 2015 at 12:00AM

from NYT Business Day http://ift.tt/1Ma4uPr

from WordPress http://ift.tt/1jUNi3y
via Hadi Aboukhater